Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lumizyme
Pharma
FDA OKs Amicus Pompe combo, setting up market battle with Sanofi
Amicus has gained a long-awaited FDA green light for its Pompe disease combination treatment combo of Pombiliti and Opfolda.
Kevin Dunleavy
Sep 28, 2023 3:15pm
Sanofi pays $180M to settle Pompe drug royalty dispute
Nov 23, 2021 1:47pm
Sanofi's late-onset Pompe prospect has scooped its green light
Aug 6, 2021 2:39pm
The world's 10 most pricey meds, topped at $1.2M
Apr 19, 2017 11:02am
